Cures 2.0 May Get Fast Tracked Due To COVID-19
Executive Summary
Follow-up bill to the 21st Century Cures Act looks to be more focused on reimbursement and delivery than the 2016 law, which centered on speeding drug development and approval. The bill's architects are working to get some of their provisions, including those around antibiotics, attached to the next COVID-19 relief legislation.
You may also be interested in...
Cures 2.0 Leaders Sees Biden ‘Advanced Research’ Project As Ticket To Bill’s Success
Reps. Diana DeGette and Fred Upton are looking to President Biden and his new plan for a translation health research group at NIH to get their next itineration of 21st Century Cures across the finish line. A discussion draft is expected in early June.
Real-World Evidence Uptake Is “Silver Lining” Of COVID-19 Response, USFDA’s Abernethy Says
The coronavirus pandemic highlights the work that is still needed on real-world evidence, agency's principal deputy commissioner says.
House Would Slow US FDA Budget Authority Increases In FY 2021
After two years of significant growth in non-user fee funds, House appropriators offer FDA a more modest increase for FY 2021.